Alzamend Neuro (ALZN) Stock Chart & Stock Price History $3.24 +0.05 (+1.57%) Closing price 04:00 PM EasternExtended Trading$3.14 -0.10 (-3.09%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alzamend Neuro Stock Price Performance The Alzamend Neuro (ALZN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 93.64%, with a year-to-date return of -68.97%. In the past month, the stock has decreased 22.49%, reflecting recent market activity. As of the latest close, Alzamend Neuro traded at $3.19 with a market cap of $2.56 million and volume of 2.45 million shares. Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.50%1 Month Performance-22.49%3 Month Performance-47.80%Year-To-Date Performance-68.97%1 Year Performance-93.64% ALZN Stock Chart for Friday, June, 13, 2025 ALZN Chart by TradingView Alzamend Neuro Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$3.34$3.19-4.49%$3.35$3.052.45 million shs$2.56 million06/11/2025$3.32$3.34+0.60%$3.40$3.29215,123 shs$2.68 million06/10/2025$3.45$3.32-3.77%$3.44$3.28143,226 shs$2.66 million06/09/2025$3.62$3.45-4.70%$3.64$3.37196,665 shs$2.76 million06/06/2025$3.72$3.62-2.69%$3.76$3.53229,399 shs$2.90 million06/05/2025$3.97$3.72-6.30%$4.00$3.68303,315 shs$2.98 million06/04/2025$3.83$3.97+3.66%$4.03$3.55646,097 shs$3.18 million06/03/2025$3.50$3.83+9.43%$4.30$3.702.46 million shs$3.07 million06/02/2025$4.03$3.50-13.15%$3.91$3.50561,482 shs$2.80 million05/30/2025$5.44$4.03-25.92%$5.20$3.702.01 million shs$3.23 million Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$3.32$5.44+63.86%$8.22$5.2177.68 million shs$4.36 million05/28/2025$3.45$3.32-3.77%$3.52$3.2535,714 shs$2.66 million05/27/2025$3.65$3.45-5.48%$3.74$3.3670,553 shs$2.76 million05/26/2025$3.65$3.65$3.65$3.4647,313 shs$2.92 million05/23/2025$3.56$3.65+2.53%$3.65$3.4647,313 shs$2.92 million05/22/2025$3.52$3.56+1.14%$3.60$3.5259,868 shs$2.85 million05/21/2025$3.52$3.52$3.55$3.4543,905 shs$2.82 million05/20/2025$3.60$3.52-2.22%$3.60$3.3485,176 shs$2.82 million05/19/2025$3.40$3.60+5.88%$3.66$3.31167,490 shs$2.88 million05/16/2025$3.29$3.40+3.34%$3.48$3.06123,095 shs$2.72 million05/15/2025$3.85$3.29-14.55%$3.83$3.16173,165 shs$23.72 million05/14/2025$4.18$3.85-7.89%$4.07$3.83237,643 shs$27.76 million05/13/2025$5.15$4.18-18.83%$6.12$3.945.77 million shs$30.13 million05/12/2025$5.92$5.15-13.05%$5.79$5.03159,478 shs$37.13 million Related Companies Calidi Biotherapeutics Stock Chart PHAXIAM Therapeutics Stock Chart Orgenesis Stock Chart Talphera Stock Chart Cyclerion Therapeutics Stock Chart Eterna Therapeutics Stock Chart Aprea Therapeutics Stock Chart Traws Pharma Stock Chart Citius Pharmaceuticals Stock Chart AEON Biopharma Stock Chart Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALZN) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
